Detalles de la búsqueda
1.
Considerations for using potential surrogate endpoints in cancer screening trials.
Lancet Oncol
; 25(5): e183-e192, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697164
2.
Years of life lost due to cancer in the United Kingdom from 1988 to 2017.
Br J Cancer
; 129(10): 1558-1568, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37726479
3.
Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial.
BMC Gastroenterol
; 23(1): 7, 2023 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36627580
4.
Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot.
Lancet Oncol
; 23(2): 270-278, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35030332
5.
A case-control study to evaluate the impact of the breast screening programme on mortality in England.
Br J Cancer
; 124(4): 736-743, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33223536
6.
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial.
Lancet Oncol
; 21(9): 1165-1172, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32800099
7.
Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting.
Int J Cancer
; 146(3): 617-626, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30861114
8.
Impact of screening on cervical cancer incidence: A population-based case-control study in the United States.
Int J Cancer
; 147(3): 887-896, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31837006
9.
Targeted Screening for Barrett's Esophagus and Esophageal Cancer: Post Hoc Analysis From the Randomized BEST3 Trial.
Gastroenterology
; 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38718951
10.
A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States.
Gynecol Oncol
; 159(2): 344-353, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32977987
11.
What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study.
Int J Cancer
; 142(4): 709-718, 2018 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29023748
12.
Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records.
Prev Med
; 111: 429-435, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29222045
13.
Range of pathologies diagnosed using a minimally invasive capsule sponge to evaluate patients with reflux symptoms.
Histopathology
; 70(2): 203-210, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27417524
14.
Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
Int J Cancer
; 139(5): 1040-5, 2016 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27096255
15.
Corrigendum to 'A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States' [Gynecologic Oncology 159 (2020) 344-353].
Gynecol Oncol
; 163(3): 614, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34602285
16.
Erratum to 'A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States' [Gynecologic Oncology 159 (2020) 344-353].
Gynecol Oncol
; 161(3): 913, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33867145
17.
Mammography screening for breast cancer-the UK Age trial - Authors' reply.
Lancet Oncol
; 21(11): e510, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152302
18.
Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case-control study.
PLoS Med
; 12(1): e1001780, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25634542
19.
An ongoing case-control study to evaluate the NHS Bowel Cancer Screening Programme.
BMC Cancer
; 14: 945, 2014 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25495609
20.
Should a Reduction in All-Cause Mortality Be the Goal When Assessing Preventive Medical Therapies?
Circulation
; 135(21): 1985-1987, 2017 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28533316